These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6105503)

  • 1. Haemolysis and renal impairment syndrome in patients on 5-fluorouracil and mitomycin-C.
    Lempert KD
    Lancet; 1980 Aug; 2(8190):369-70. PubMed ID: 6105503
    [No Abstract]   [Full Text] [Related]  

  • 2. Rash, nephritis, hypertension, and haemolysis in patient on 5-fluorouracil, doxorubicin, and mitomycin-C.
    Karlin DA; Stroehlein JR
    Lancet; 1980 Sep; 2(8193):534-5. PubMed ID: 6105582
    [No Abstract]   [Full Text] [Related]  

  • 3. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 4. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
    Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 6. [Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
    Ito S; Hirono S
    Rinsho Ketsueki; 1982 May; 23(5):730-5. PubMed ID: 6813535
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
    Waldhorn RE; Tsou E; Smith FP; Kerwin DM
    Med Pediatr Oncol; 1984; 12(6):394-6. PubMed ID: 6548790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible microangiopathic hemolytic anemia after mitomycin C.
    Perry DJ
    Cancer Chemother Pharmacol; 1983; 10(3):223. PubMed ID: 6407770
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
    Crocker J; Jones EL
    J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience of a combination chemotherapy consisting of 5-FU, MMC, and FT-207--side effects against kidney].
    Yamada F; Kagami H; Fukutome A; Mastumine T; Miura T
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2049-54. PubMed ID: 6412636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal toxicity of mitomycin-C.
    Ravikumar TS; Sibley R; Reed K; Grage TB
    Am J Clin Oncol; 1984 Jun; 7(3):279-85. PubMed ID: 6428215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular haemolysis and renal impairment after blood transfusion in two patients on long-term 5-fluorouracil and mitomycin-C.
    Jones BG; Fielding JW; Newman CE; Howell A; Brookes VS
    Lancet; 1980 Jun; 1(8181):1275-7. PubMed ID: 6104085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil.
    Gulati SC; Sordillo P; Kempin S; Reich L; Magill GB; Scheiner E; Clarkson B
    Cancer; 1980 May; 45(9):2252-7. PubMed ID: 7379025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
    Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
    Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2 cases of aplastic anemia and renal disorders due to mitomycin C].
    Tomura T; Takizawa Y; Irikae K; Korenaga O; Higo O
    Gan No Rinsho; 1966 Mar; 12(3):173-6. PubMed ID: 6010939
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal complications of mitomycin C therapy with special reference to the total dose.
    Valavaara R; Nordman E
    Cancer; 1985 Jan; 55(1):47-50. PubMed ID: 3917353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal failure and hemolytic anemia associated with mitomycin C. A case report.
    Price TM; Murgo AJ; Keveney JJ; Miller-Hardy D; Kasprisin DO
    Cancer; 1985 Jan; 55(1):51-6. PubMed ID: 3917354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR; Levy SM; Michaels RS; Zirkin RM
    Henry Ford Hosp Med J; 1983; 31(2):104-9. PubMed ID: 6313552
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
    McCarthy JT; Staats BA
    Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.